Loading clinical trials...
Loading clinical trials...
Phase II Study of Neoadjuvant IMC-A12 Combined With Androgen Deprivation Prior to Prostatectomy
Conditions
Interventions
IMC-A12
Bicalutamide
+1 more
Locations
3
United States
Virginia Mason Medical Center
Seattle, Washington, United States
Seattle Cancer Care Alliance
Seattle, Washington, United States
University of Washington Medical Center
Seattle, Washington, United States
Start Date
October 1, 2008
Primary Completion Date
August 1, 2011
Completion Date
November 1, 2011
Last Updated
March 29, 2017
NCT06926283
NCT06594926
NCT06844383
NCT07177937
NCT05919264
NCT07004582
Lead Sponsor
University of Washington
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions